BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32088612)

  • 1. LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study.
    Budania S; Sur D; Nangal J; Pilli S; Mukherjee K; Biswas M; Prasad R; Saxena S; Mandal PK
    Cancer Genet; 2020 Jun; 244():21-29. PubMed ID: 32088612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
    Mukherjee K; Sur D; Singh A; Rai S; Das N; Sekar R; Narindi S; Dhingra VK; Jat B; Balraam KVV; Agarwal SP; Mandal PK
    BMC Cancer; 2021 May; 21(1):628. PubMed ID: 34044801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
    Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nucleolin Antagonist N6L Inhibits LINE1 Retrotransposon Activity in Non-Small Cell Lung Carcinoma Cells.
    Ramos KS; Moore S; Runge I; Tavera-Garcia MA; Cascone I; Courty J; Reyes-Reyes EM
    J Cancer; 2020; 11(3):733-740. PubMed ID: 31942196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer.
    Chen L; Dahlstrom JE; Chandra A; Board P; Rangasamy D
    Breast Cancer Res Treat; 2012 Nov; 136(1):129-42. PubMed ID: 23053642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing Complex Nucleic Acid Interactions of LINE1 ORF1p by Single Molecule Force Spectroscopy.
    Naufer MN; Williams MC
    Methods Mol Biol; 2020; 2106():283-297. PubMed ID: 31889265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
    Zhao C; Zou H; Zhang J; Wang J; Liu H
    Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
    Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
    Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.
    Foy JP; Pickering CR; Papadimitrakopoulou VA; Jelinek J; Lin SH; William WN; Frederick MJ; Wang J; Lang W; Feng L; Zhang L; Kim ES; Fan YH; Hong WK; El-Naggar AK; Lee JJ; Myers JN; Issa JP; Lippman SM; Mao L; Saintigny P
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1027-35. PubMed ID: 26342026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter-associated DNA methylation & expression profiling of genes (
    Khongsti S; Shunyu BN; Ghosh S
    Indian J Med Res; 2019 Dec; 150(6):584-591. PubMed ID: 32048621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINE-1 Retrotransposition Promotes the Development and Progression of Lung Squamous Cell Carcinoma by Disrupting the Tumor-Suppressor Gene FGGY.
    Zhang R; Zhang F; Sun Z; Liu P; Zhang X; Ye Y; Cai B; Walsh MJ; Ren X; Hao X; Zhang W; Yu J
    Cancer Res; 2019 Sep; 79(17):4453-4465. PubMed ID: 31289132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma.
    Clausen MJ; Melchers LJ; Mastik MF; Slagter-Menkema L; Groen HJ; van der Laan BF; van Criekinge W; de Meyer T; Denil S; Wisman GB; Roodenburg JL; Schuuring E
    Genes Chromosomes Cancer; 2016 Jan; 55(1):45-59. PubMed ID: 26391330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic dysregulation-mediated alterations of key biological pathways and tumor immune evasion are hallmarks of gingivo-buccal oral cancer.
    Das D; Ghosh S; Maitra A; Biswas NK; Panda CK; Roy B; Sarin R; Majumder PP
    Clin Epigenetics; 2019 Dec; 11(1):178. PubMed ID: 31796082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of L1-Ribonucleoprotein Particles (L1-RNPs) from Cultured Human Cells.
    Mandal PK; Kazazian HH
    Methods Mol Biol; 2016; 1400():299-310. PubMed ID: 26895061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.
    Zhang J; Ling T; Wu H; Wang K
    J Oral Pathol Med; 2015 Sep; 44(8):578-84. PubMed ID: 25370482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.